Annovis Bio (ANVS)
(Delayed Data from NYSE)
$9.14 USD
+1.16 (14.54%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $9.10 -0.04 (-0.44%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.64 |
EPS Last Quarter | -0.44 |
Last EPS Surprise | 37.14% |
ABR | 1.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.53 |
Next Year | -1.84 |
EPS (TTM) | -3.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.64 | -0.61 | -2.53 | -1.84 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.38 | -0.30 | -3.61 | -2.18 |
High Estimate | -0.38 | -0.30 | -1.96 | -1.50 |
Low Estimate | -0.89 | -0.91 | -3.61 | -2.18 |
Year ago EPS | -1.63 | -1.09 | -4.92 | -2.53 |
Year over Year Growth Est. | 60.74% | 44.04% | 48.58% | 27.14% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.64 | -0.61 | -2.53 | -1.84 |
7 Days Ago | -0.64 | -0.61 | -2.53 | -1.84 |
30 Days Ago | -0.64 | -0.61 | -2.53 | -1.84 |
60 Days Ago | -0.64 | -0.61 | -2.46 | -1.75 |
90 Days Ago | -0.64 | -0.60 | -2.46 | -1.91 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.64 | -0.61 | -2.53 | -1.84 |
Zacks Consensus Estimate | -0.64 | -0.61 | -2.53 | -1.84 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.44 | -0.72 | -1.09 | -1.63 | NA |
Estimate | -0.70 | -0.87 | -1.35 | -1.10 | NA |
Difference | 0.26 | 0.15 | 0.26 | -0.53 | 0.04 |
Surprise | 37.14% | 17.24% | 19.26% | -48.18% | 6.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more